Isopentyl caffeate as a promising drug for the treatment of leishmaniasis: An in silico and in vivo study

Leishmaniasis is recognised as the second largest parasitic disease worldwide and yet a neglected disease. The current pharmacological treatments are associated with significant challenges, including high toxicity, high cost and parasitic resistance. Considering the potential of isopentyl caffeate (...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Wanessa S. Mota, Simone S.C. Oliveira, Matheus M. Pereira, Damião P. Souza, Mayara Castro, Pollyanna S. Gomes, Herbert L.M. Guedes, Vinícius F. Souza, André L.S. Santos, Ricardo L.C. Albuquerque-Junior, Juliana C. Cardoso, Cristina Blanco-Llamero, Sona Jain, Eliana B. Souto, Patrícia Severino
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2024-01-01
coleção:	Current Research in Biotechnology
Assuntos:	Leishmania Isopentyl caffeate In silico Pharmacokinetics ADME Bioavailability
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2590262824000352
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!